October 27, 2025

Decreasing CHF Readmissions with Zoll HFMS: Sentara Virginia Beach General Hospital Pilot Study

Chelsea Christensen, PA with Sentara Cardiology Specialists, describes a patient monitoring protocol using radiofrequency technology to detect CHF symptoms to prevent hospital readmissions. 

Sentara

October 17, 2025

Your Guide to Referring to the Center for Heart Rhythm Disorders

The Center for Heart Rhythm Disorders at Miami Cardiac & Vascular Institute offers streamlined, expert evaluation and management of arrhythmias.

Baptist Health South Florida

October 10, 2025

Seaport Criteria Bring Clarity to Myocarditis Grading

New guidelines combine hematoxylin and eosin and CD3 staining to improve diagnostic accuracy and reproducibility worldwide

The Pathologist

October 07, 2025

UCI Health launches first U.S. trial of nerve-blocking device for drug-resistant hypertension

A new clinical trial at UCI Health tests a novel device that could help millions with uncontrolled high blood pressure reduce or eliminate medications.

UCI Health

October 02, 2025

Understanding Group 2 Pulmonary Hypertension: Implications for Future Clinical Trials

Dr. Benza discusses the pathophysiology and management principles of Group 2 pulmonary hypertension.

Sentara

September 30, 2025

Positive Airway Pressure Therapy and Cardiometabolic Risk: Evidence from a Multicenter Registry

Sleep Apnea (SA) is a recognized risk factor for hypertension, cardiovascular disease, and metabolic dysfunction

Baptist Health South Florida

September 29, 2025

ACC Calls for Universal Inflammation Screening

New scientific statement positions hsCRP testing alongside cholesterol as evidence mounts for targeting residual inflammatory risk. 

Conexiant

September 20, 2025

Join Mount Sinai at Top Ten Topics in Clinical Cardiology 2025, Oct 17, 2025

The Top Ten Topics in Cardiology 2025 is a live, in-person educational course designed to deliver timely, practical, and clinically relevant updates in the field of cardiovascular medicine. Led by internationally recognized experts from Mount Sinai and beyond, this one-day conference will focus on major advances across the spectrum of cardiovascular care.

Mount Sinai New York

January 31, 2018

Reducing Revitrectomy Risk

A Finnish study suggests that systemic statins lower the risk of revitrectomy in RRD by 28 percent

The Ophthalmologist